Skip to content
Search

Latest Stories

Boots Pharmacy at Bungay Medical Centre to close on March 9

The pharmacy chain has confirmed to shut 16 stores this year, with more expected to be announced later in the year

The rumours are true, the Boots Pharmacy at the Bungay Medical Centre in Suffolk is closing soon as part of the pharmacy chain’s cost-cutting plan.


The store has put up a notice to inform the public that it will pull the shutter down permanently on March 9.

The announcement has left people in the market town frustrated, as the chemist was right next to the doctors, and it is easily accessible.

Bungay mayor, Frances Betts, told Eastern Daily Press that the closure will be a “big loss” for the town.

She said that while the council was aware of the closure rumours, they have not been informed by Boots themselves, and that has saddened them.

Frances added the issue will be discussed at their next full council as “any shop closure is not good for the town.”

There is another Boots branch in the town at St Mary's Street which is 0.5 miles away, but it doesn’t have a car park, which is the main concern raised by some of the people in the town.

After closing 20 stores last year, Boots has confirmed 16 stores that are set to close this year, with more expected to be announced later in the year.

In July 2023, the retailer announced its decision to close 300 branches located “in close proximity to each other” over the next 12 months to reduce its portfolio from around 2,200 to 1,900.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less